Related Experiment Video
Updated: Nov 13, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Delirium and Mortality in Coronavirus Disease 2019 (COVID-19) - A Systematic Review and Meta-analysis
Raymond Pranata1, Ian Huang2, Michael Anthonius Lim1
1Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia.
Insights
Delirium significantly increases mortality risk in older adults hospitalized with COVID-19. This meta-analysis confirms a strong association between delirium and death in this vulnerable population.
Area of Science:
- Gerontology
- Infectious Diseases
- Critical Care Medicine
Background:
- Older adults are disproportionately affected by COVID-19.
- Delirium is a common complication in hospitalized patients.
- The association between delirium and mortality in COVID-19 patients requires further investigation.
Purpose of the Study:
- To conduct a meta-analysis to determine the association between delirium and mortality in older adults with COVID-19.
- To synthesize evidence from existing studies on this topic.
Main Methods:
- Systematic literature searches of PubMed, Embase, and Scopus databases were conducted.
- Studies included patients diagnosed with delirium using validated criteria.
- Mortality was the primary outcome, with effect estimates reported as odds ratios (ORs) and adjusted odds ratios (aORs).
Main Results:
- The meta-analysis included 3,868 patients from 9 studies.
- Delirium was present in 27% of patients and was significantly associated with mortality (OR 2.39).
- Adjusted analysis confirmed delirium as an independent predictor of mortality (aOR 1.50), with subgroup analysis showing similar associations for delirium at admission.
Conclusions:
- Delirium is associated with an increased risk of mortality in hospitalized older adults with COVID-19.
- The findings highlight the importance of monitoring and managing delirium in this patient group.
- Further research should explore interventions to mitigate delirium-related mortality in COVID-19 patients.
Introduction:
Older adults are indisputably struck hard by the coronavirus disease 2019 (COVID-19) pandemic. The main objective of this meta-analysis is to establish the association between delirium and mortality in older adults with COVID-19.
Methods:
Systematic literature searches of PubMed, Embase, and Scopus databases were performed up until 28 November 2020. The exposure in this study was the diagnosis of delirium using clinically validated criteria. Delirium might be in-hospital, at admission, or both. The main outcome was mortality defined as clinically validated non-survivor/death. The effect estimates were reported as odds ratios (ORs) and adjusted odds ratios (aORs).
Results:
A total of 3,868 patients from 9 studies were included in this systematic review and meta-analysis. The percentage of patients with delirium was 27% [20%, 34%]. Every 1 mg/L increase in CRP was significantly associated with 1% increased delirium risk (OR 1.01 [1.00. 1.02], p=0.033). Delirium was associated with mortality (OR 2.39 [1.64, 3.49], p<0.001; I2: 82.88%). Subgroup analysis on delirium assessed at admission indicate independent association (OR 2.12 [1.39, 3.25], p<0.001; I2: 82.67%). Pooled adjusted analysis indicated that delirium was independently associated with mortality (aOR 1.50 [1.16, 1.94], p=0.002; I2: 31.02%). Subgroup analysis on delirium assessed at admission indicate independent association (OR 1.40 [1.03, 1.90], p=0.030; I2: 35.19%). Meta-regression indicates that the association between delirium and mortality were not significantly influenced by study-level variations in age, sex [reference: male], hypertension, diabetes, and dementia.
Conclusion:
The presence of delirium is associated with increased risk of mortality in hospitalized older adults with COVID-19.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pneumonia III: Complications and Assessment
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Bias in Epidemiological Studies

